Patents by Inventor Alfredo Gorio

Alfredo Gorio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220177837
    Abstract: A method for culturing cells on a substrate capable of inducing pluripotency is provided. The method includes plating cells on a nichoid-type substrate, allowing cultured cells to proliferate for a certain period of time, detaching cells from the nichoid-type substrate, and, once cells have been detached, culturing cells in suspension or under adhesion.
    Type: Application
    Filed: March 9, 2020
    Publication date: June 9, 2022
    Inventors: Stefania CARELLI, Manuela Teresa RAIMONDI, Anna Maria DI GIULIO, Toniella GIALLONGO, Alfredo GORIO, Giulio Nicola CERULLO, Roberto OSELLAME
  • Publication number: 20190024055
    Abstract: A method for promoting anti-inflammatory properties and for improving repair ability of a tissue containing mesenchymal stem cells (MSCs) includes causing a mechanical activation by applying a orbital shaking force on an adipose tissue lipoaspirated or removed from a body.
    Type: Application
    Filed: December 28, 2016
    Publication date: January 24, 2019
    Inventor: Alfredo Gorio
  • Publication number: 20030100505
    Abstract: Compositions and methods useful in therapy for IGF-I-responsive conditions in a mammal are provided. The method comprises concurrent therapy with both IGF-I or a variant thereof and at least one GAG to promote a desired therapeutic response with respect to a particular IGF-I-responsive condition. Concurrent therapy is achieved by administering to a mammal a single pharmaceutical composition containing both IGF-I (or a variant thereof) and at least one GAG according to a dosing regimen. Alternatively, IGF-I or a variant thereof and at least one GAG can be administered as two separate pharmaceutical compositions. A pharmaceutical composition comprising IGF-I or a variant thereof and at least one GAG for use in the IGF-I and GAG therapy is also provided.
    Type: Application
    Filed: October 24, 2002
    Publication date: May 29, 2003
    Applicant: Chiron Corporation
    Inventors: Bruce F. Scharschmidt, Alfredo Gorio, Eugenio E. Muller
  • Patent number: 5116873
    Abstract: Oral or parenteral administration of thyroid hormone T.sub.4 (from 0.5 to 2 .mu.g/100 g of body weight) stimulates, normalizes dopaminergic innervation in the corpus striatum (striate body), and restores neurochemical compensation following denervation of selective brain areas, thereby increasing neuronal plasticity.
    Type: Grant
    Filed: December 7, 1990
    Date of Patent: May 26, 1992
    Inventors: Alfredo Gorio, Enrico Genazzani